Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The neuronal α7 nicotinic acetylcholine receptor (α7 nAChR) is a ligand-gated ion channel composed of five α7 subunits. It is highly permeable to calcium ions and exhibits rapid desensitization. Expressed throughout the CNS and PNS, it modulates synaptic activity, cognitive processes, and inflammation. It is implicated in diseases like schizophrenia, Alzheimer's, and cancer, and is a target for therapeutic interventions.
Agonist or antagonist binding to the receptor, modulating ion channel opening and calcium influx.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuronal Nicotinic Acetylcholine Receptor α7 Subtype (α7 nAChR).